Healthcare Cold-Chain Qualification Director — Consulting

The mandate

The problem is the absence of end-to-end qualification evidence for six new biologics lanes. Component certificates exist, but packaging, dwell, hand-offs, monitoring and excursion decisions have not been tested as one system.

The output is a lane risk assessment, protocol set, executed seasonal simulations, monitoring design, excursion decision tree, training evidence and a launch qualification dossier.

Milestone one is due 25 September 2026 with risks and approved protocols; milestone two on 30 October with completed chamber and route tests; milestone three on 27 November with closed deviations, trained operators and final dossier.

The Launch Readiness Committee accepts only when every worst-case lane passes predefined temperature and custody criteria, deviations have effective corrective action, quality approves the excursion tree and operators demonstrate competency.

The client provides product stability data, packaging samples, carrier access, monitoring devices, facilities and quality reviewers. Commercial launch dates cannot override a failed protocol; retesting follows formal change control.

Why this is external work

Internal quality teams are preparing multiple launches and cannot independently author and witness every test. The client needs specialist thermal and distribution qualification capability for a fixed window. External execution also provides evidence separate from carrier self-certification.

What you will own

• Risk-rank six lanes by stability, dwell, hand-off and ambient exposure.
• Write acceptance-led chamber, route, custody and device protocols for milestone one.
• Execute worst-case packaging and route simulations with witnessed evidence.
• Investigate deviations and retest only after approved corrective action.
• Design monitoring placement, alerts and excursion-decision logic.
• Verify carrier and client operator competency before release.
• Compile the milestone-three qualification dossier for committee approval.

Candidate qualifications

• 18–22 years in pharmaceutical quality, biologics logistics or cold-chain validation.
• Direct authorship and execution of lane and packaging qualifications.
• Knowledge of stability, thermal mapping, monitoring, custody and deviation controls.
• Evidence of rejecting a launch lane that failed predefined protocol.
• Experience training carriers and distribution operators to verified competence.
• Ability to produce inspection-ready qualification dossiers.

Non-negotiables

• No carrier, packaging or monitoring-device sales interest.
• Director witnesses all worst-case simulations and critical retests.
• Quality-approved protocols precede every execution run.
• Failed criteria cannot be waived through commercial acceptance.

1. 49 words maximum. Which biologics lane qualification did you lead, and what failed test changed packaging or route design?
2. 49 words maximum. How would you define worst-case conditions for six metropolitan lanes?
3. 49 words maximum. Which stability, packaging and carrier inputs are required before protocol approval?